Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
Gerrit Kann,1,* Junaid Owasil,1,* Karina Kuczka,2 Annette Haberl,1 Timo Wolf,1 Pavel Khaykin,1 Sebastian Harder,2 Christoph Stephan,1 Nils von Hentig1 1HIVCENTER, Medical HIV Treatment and Research Unit, Johann Wolfgang Goethe University Frankfurt, Frankfurt am Main, Germany; 2Pharma...
Guardado en:
Autores principales: | Kann G, Owasil J, Kuczka K, Haberl A, Wolf T, Khaykin P, Harder S, Stephan C, von Hentig N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/962caca7d0c04f0db75e9266fc9947a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IMMUNOLOGICAL METHODS FOR EVALUATION OF PLATELET FUNCTIONS IN THE PATIENTS WITH CARDIOVASCULAR DISEASES
por: O. V. Sirotkina, et al.
Publicado: (2014) -
<italic toggle="yes">In Vivo</italic> Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
por: Rawlings Datir, et al.
Publicado: (2020) -
Probing the Pharmacological Binding Properties, and Reactivity of Selective Phytochemicals as Potential HIV-1 protease Inhibitors
por: Ammara Akhtar, Waqar Hussain, Nouman Rasool3
Publicado: (2019) -
The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation
por: Sébastien Lyonnais, et al.
Publicado: (2021) -
Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
por: Roberta Rinaldi, et al.
Publicado: (2021)